Medpace (MEDP) PT Raised to $625 at Barclays

October 7, 2026 3:50 AM

Barclays analyst Luke Sergott raised the price target on Medpace (NASDAQ: MEDP) to $625.00 (from $600.00) while maintaining a Equalweight rating.

No results found